2.78
                                            
            Stereotaxis Inc stock is traded at $2.78, with a volume of 808.70K.
            It is down -4.47% in the last 24 hours and down -11.46% over the past month.
            Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
        
        See More
    Previous Close:
              $2.91
            Open:
              $2.93
            24h Volume:
                808.70K
            Relative Volume:
              1.63
            Market Cap:
                $253.18M
            Revenue:
              $25.14M
            Net Income/Loss:
              $-21.57M
            P/E Ratio:
              -10.30
            EPS:
                -0.27
            Net Cash Flow:
                $-12.23M
            1W Performance:
              -8.85%
            1M Performance:
              -11.46%
            6M Performance:
                +37.62%
            1Y Performance:
              +43.30%
            Stereotaxis Inc Stock (STXS) Company Profile
Name
                  
                      Stereotaxis Inc
                    
                Sector
                  Industry
                  Phone
                  
                      314-678-6100
                    
                Address
                  
                      4320 Forest Park Avenue, Suite 100, St. Louis, MO
                    
                Compare STXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                STXS
                            
                             
                        Stereotaxis Inc 
                           | 
                    2.78 | 265.01M | 25.14M | -21.57M | -12.23M | -0.27 | 
| 
                         
                          
                                ISRG
                            
                             
                        Intuitive Surgical Inc 
                           | 
                    544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 | 
| 
                         
                          
                                BDX
                            
                             
                        Becton Dickinson Co 
                           | 
                    177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 | 
| 
                         
                          
                                ALC
                            
                             
                        Alcon Inc 
                           | 
                    73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 | 
| 
                         
                          
                                RMD
                            
                             
                        Resmed Inc 
                           | 
                    248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 | 
| 
                         
                          
                                WST
                            
                             
                        West Pharmaceutical Services Inc 
                           | 
                    279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 | 
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change | 
|---|---|---|---|
| Jan-10-24 | Initiated | ROTH MKM | Buy | 
| Jul-12-22 | Initiated | Aegis Capital | Buy | 
| Jun-23-22 | Initiated | B. Riley Securities | Buy | 
| Jan-05-22 | Initiated | Craig Hallum | Buy | 
| Jan-05-22 | Initiated | Loop Capital | Buy | 
| May-26-21 | Initiated | Piper Sandler | Overweight | 
| Sep-08-20 | Initiated | Northland Capital | Outperform | 
| Apr-09-20 | Initiated | Cowen | Outperform | 
| Apr-07-20 | Initiated | Lake Street | Buy | 
                    View All
                    
                  
                Stereotaxis Inc Stock (STXS) Latest News
What the charts say about Stereotaxis Inc. todayWeekly Market Report & Weekly Top Gainers Alerts - newser.com
Stereotaxis Inc. stock momentum explainedMarket Performance Summary & Technical Confirmation Trade Alerts - newser.com
Is Stereotaxis Inc. stock poised for growthEntry Point & Verified Technical Trade Signals - newser.com
Using AI based signals to follow Stereotaxis Inc.July 2025 Recap & Expert Curated Trade Ideas - newser.com
How strong is Stereotaxis Inc. stock balance sheetTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
What technical models suggest about Stereotaxis Inc.’s comebackJuly 2025 Rallies & Low Drawdown Trading Strategies - newser.com
Can Stereotaxis Inc. stock test all time highsJuly 2025 Volume & Consistent Growth Equity Picks - newser.com
Will Stereotaxis Inc. stock maintain growth storyWeekly Trade Analysis & Stock Portfolio Risk Management - newser.com
Order flow analysis tools used on Stereotaxis Inc.2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Why Stereotaxis Inc. stock could see breakout soon2025 Investor Takeaways & Weekly Chart Analysis and Guides - newser.com
How Stereotaxis Inc. stock trades before earningsJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
Why Stereotaxis Inc. stock could outperform in 2025Portfolio Profit Report & Long Hold Capital Preservation Tips - newser.com
Is Stereotaxis Inc. stock trading near support levelsInsider Buying & AI Enhanced Trade Execution Alerts - newser.com
Will Stereotaxis Inc. stock outperform tech sector in 2025Weekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Can Stereotaxis Inc. stock continue upward trendJuly 2025 Selloffs & Verified High Yield Trade Plans - newser.com
Visualizing Stereotaxis Inc. stock with heatmapsEarnings Overview Summary & Consistent Return Strategy Ideas - newser.com
Can Stereotaxis Inc. stock retain market dominanceBreakout Watch & Verified Technical Trade Signals - newser.com
Stereotaxis Inc (RJR1.DU) Stock Forum & Discussion - Yahoo! Finance Canada
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):